Patient-Reported (EORTC QLQ-CIPN20) Versus Physician-Reported (CTCAE) Quantification of Oxaliplatin- and Paclitaxel/Carboplatin-Induced Peripheral Neuropathy in NCCTG/Alliance Clinical Trials

PURPOSE: Clinical practice guidelines on chemotherapy-induced peripheral neuropathy (CIPN) use the NCI Common Terminology Criteria for Adverse Events (CTCAE), while recent clinical trials employ a potentially superior measure, the European Organization for Research and Treatment of Cancer Quality of...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Support Care Cancer
Autores principales: Le-Rademacher, Jennifer, Kanwar, Rahul, Seisler, Drew, Pachman, Deirdre R., Qin, Rui, Abyzov, Alexej, Ruddy, Kathryn J., Banck, Michaela S., Lavoie Smith, Ellen M., Dorsey, Susan G., Aaronson, Neil K., Sloan, Jeff, Loprinzi, Charles L., Beutler, Andreas S.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2017
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5693734/
https://ncbi.nlm.nih.gov/pubmed/28634656
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00520-017-3780-y
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares